首页> 美国卫生研究院文献>Cancer Medicine >Kinetics of postdiagnosis platelet count with overall survival of pancreatic cancer: a counting process approach
【2h】

Kinetics of postdiagnosis platelet count with overall survival of pancreatic cancer: a counting process approach

机译:诊断后血小板计数与胰腺癌总生存期的动力学:计数过程

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

The association between long‐term variation of postdiagnosis platelets and survival of pancreatic cancer (PC) has never been discussed by using dynamic survival analysis method. In this retrospective study, we analyzed 311 histologically confirmed PC patients identified from a mega population‐based electronic inpatients database from 2012 to 2013 in China. Counting process approach was applied to restructure the original survival data, the association between post‐diagnosis platelet count and overall survival (OS) of PC was evaluated by multiple failure‐time Cox proportional hazards model. After counting process adjustment, multiple failure‐time Cox proportional hazards model revealed that, regardless of the treatment modalities PC patients received, postdiagnosis thrombocytopenia was prominently associated with OS, compared with PC patients with normally ranged platelet count, the HRs ranged from 2.04 (95% CI: 1.14–3.67) to 10.82 (95% CI: 2.63–44.54), and this inverse association was robust based on further sensitivity analysis. On the contrary, the association between thrombocytosis and OS of PC tended to be inconclusive. Our findings suggested that postdiagnosis thrombocytopenia was associated with significantly compromised survival among PC patients from this large retrospective cohort. Underlying mechanisms behind this association should be further investigated.
机译:使用动态生存分析方法从未讨论过诊断后血小板长期变化与胰腺癌(PC)生存之间的关系。在这项回顾性研究中,我们分析了2012年至2013年间从以人口为基础的超大型电子住院患者数据库中鉴定出的311例经组织学确认的PC患者。应用计数过程方法重建原始生存数据,并通过多重失效时间Cox比例风险模型评估诊断后血小板计数与PC总体生存(OS)之间的关联。在对过程调整进行计数后,多重失效时间Cox比例风险模型显示,无论PC患者接受何种治疗方式,与血小板计数正常范围的PC患者相比,诊断后血小板减少症与OS显着相关,HR范围为2.04(95 %CI:1.14-3.67)到10.82(95%CI:2.63-44.54),并且根据进一步的敏感性分析,这种逆相关性很强。相反,血小板增多与PC OS之间的关联性尚无定论。我们的研究结果表明,来自这一大型回顾性队列研究的患者中,诊断后的血小板减少症与生存率显着降低有关。该协会背后的潜在机制应进一步研究。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号